Zobrazeno 1 - 8
of 8
pro vyhledávání: '"Angel B. Jaramillo"'
Autor:
David A. Cooper, Don Smith, Julian Sutton, Victor Appay, Pat Grey, Anthony D. Kelleher, Sarah Rowland-Jones, Philippa Easterbrook, Angel B. Jaramillo, John Zaunders, Laura Papagno, Andrew J. McMichael, Anele Waters
The cytotoxic potential of CD8+ T cells and NK cells plays a crucial role in the immune response to pathogens. Although in vitro studies have reported that CD4+ T cells are also able to mediate perforin-mediated killing, the in vivo existence and rel
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=doi_dedup___::7330443cb433e30a45054945c1555edd
https://ora.ox.ac.uk/objects/uuid:2608eed1-ef53-4a85-a621-e12d1c7966f1
https://ora.ox.ac.uk/objects/uuid:2608eed1-ef53-4a85-a621-e12d1c7966f1
Autor:
David A. Cooper, Jan Harris, Irene Gow, Angel B. Jaramillo, Monika Roggensack, Alan Walker, Gary Patou, Marilyn McMurchie, Don Smith, Anthony D. Kelleher
Publikováno v:
AIDS. 12:175-182
OBJECTIVES To evaluate the impact of therapeutic immunization with p24 virus-like particle (VLP) and zidovudine (ZDV) on p24 antibody titre (primary endpoint), CD4+ cell counts, cellular responses to the immunogen and recall antigens, and viral load
Autor:
Beth Everett, Ian A. Ramshaw, Ke Gao, Kerrie J. Dunstan, Charani Ranasinghe, Jill Medveckzy, Maryanne Shoobridge, Angel B. Jaramillo, Scott Thomson, Stephen J. Kent, Rosemary A. Ffrench
Publikováno v:
Vaccine. 23(38)
Induction of high levels of broadly reactive cytotoxic T lymphocytes (CTL) remains a promising approach for an effective HIV-1 vaccine. We have developed a novel genetic-based vaccine strategy that encodes consensus overlapping peptide sets from all
Autor:
Rowanne Wright, Gilbert R. Kaufmann, Jeanette Vizzard, Andrew Carr, Don Smith, Angel B. Jaramillo, Pat Grey, John Zaunders, Anthony D. Kelleher, Philip Cunningham, David A. Cooper
Publikováno v:
The Journal of infectious diseases. 180(2)
Antiretroviral therapy commenced during primary human immunodeficiency virus type 1 (HIV-1) infection (PHI) may limit the extent of viral replication and prevent early loss of HIV-specific CD4 lymphocyte function. We studied the effect of current sta
Autor:
Tanya L. Applegate, Glen J Mcintyre, Geoff Symonds, Donald J. Birkett, John M. Murray, Angel B Jaramillo
Publikováno v:
Retrovirology, Vol 7, Iss 1, p 83 (2010)
Retrovirology
Retrovirology
Background Gene therapy has the potential to counter problems that still hamper standard HIV antiretroviral therapy, such as toxicity, patient adherence and the development of resistance. RNA interference can suppress HIV replication as a gene therap
Autor:
Jennifer Lynne Groneman, Tanya L. Applegate, Angel B Jaramillo, Sylvie Shen, Yi-Hsin Yu, Glen J Mcintyre
Publikováno v:
Retrovirology
Retrovirology, Vol 6, Iss 1, p 55 (2009)
Retrovirology, Vol 6, Iss 1, p 55 (2009)
Background The RNA interference (RNAi) pathway is a mechanism of gene-suppression with potential gene therapy applications for treating viral disease such as HIV-1. The most suitable inducer of RNAi for this application is short hairpin RNA (shRNA) a
Publikováno v:
Virology Journal. 2009, Vol. 6, p184-198. 15p.
Publikováno v:
Scandinavian Journal of Immunology. Jul/Aug2001 Supplement 1, Vol. 54, p2-2. 1p.